Posaconazole Prophylaxis for CAPA Prevention in Critically-Ill Patients (Q113933254)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Posaconazole Prophylaxis for CAPA Prevention in Critically-Ill Patients |
clinical trial |
Statements
POSACOVID (English)
0 references
Posaconazole for the Prevention of COVID-19 Associated Pulmonary Aspergillosis in Critically-Ill Patients: A European Multicenter Case-Control Study (English)
0 references
1 March 2020
0 references
September 2022
0 references
351
0 references
18 year
0 references